Opinion
Video
Summary and Forward Looking for RCC
Author(s):
In her concluding remarks, Laurence Albiges, MD, PhD, shares her final thoughts and expresses optimism for the future landscape of renal cell carcinoma treatments.
EP: 1.Evolving Treatment Standards in Non-Clear Cell RCC
EP: 2.Extended Follow Up of KEYNOTE-B61
EP: 3.Ongoing Clinical Trials in the front-line setting of advanced non-clear cell RCC
EP: 4.STELLAR 304: Zanzalintinib plus nivolumab in non-clear cell RCC
EP: 5.Case Presentation: 61-year-old male Renal Cell Carcinoma
EP: 6.Use of Combination Regimens in Frontline RCC
EP: 7.Treatment Decision Making in first-line combinations for advanced RCC
EP: 8.AE Management for Combination Regimens in Advanced RCC
EP: 9.AE Management for Combination Regimens in Advanced RCC
EP: 10.Optimizing Treatment in Advanced RCC
EP: 11.Dr Albiges Discusses a Non-Clear Cell RCC Patient Profile
EP: 12.Updates in the Treatment Approach for Non-clear cell RCC
EP: 13.Dr Albiges Reviews Long term follow up data from KEYNOTE-B61
EP: 14.Emerging Therapies in the Front-line Setting of Advanced non-clear cell RCC
EP: 15.Biomarker-driven combination treatment approach in non-clear cell RCC (Met-driven)
Now Viewing
EP: 16.Summary and Forward Looking for RCC
Related Videos
Related Content
